0.33Open0.33Pre Close0 Volume234 Open Interest76.00Strike Price0.00Turnover2038.88%IV5.70%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.33Extrinsic Value100Contract SizeAmericanOptions Type-0.1455Delta0.0531Gamma243.15Leverage Ratio-194.4380Theta0.0000Rho-35.39Eff Leverage0.0005Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet